10.1007/s11064-012-0775-4 32 ChechowskaM.GajewskaJ.SzczepanikE.MazurJ.CycholA.Kuniar-PakaA.et al (2025)
Both stimulants and GLP-1 drugs suppress appetite, so under-eating and poor nutrition are real risks
Fatty liver: Can lead to fatty liver disease, which may progress to liver dysfunction, cirrhosis, or require liver transplant
For this reason, researchers are exploring potential behavioral effects of GLP-1 medications, even though this is not their intended or approved use
Yeah, he can sound pissed off at times, but what would you expect from a pediatrician who has experienced more and more children piling up at his exam room door with diseases that were once only associated with older adults
In results published in February, people taking MariTide in an early-stage trial lost up to more than 14 percent of their body weight in 12 weeks